D M Goldenberg

2.7k total citations
85 papers, 2.1k citations indexed

About

D M Goldenberg is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology and Oncology. According to data from OpenAlex, D M Goldenberg has authored 85 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Radiology, Nuclear Medicine and Imaging, 27 papers in Molecular Biology and 25 papers in Oncology. Recurrent topics in D M Goldenberg's work include Radiopharmaceutical Chemistry and Applications (38 papers), Monoclonal and Polyclonal Antibodies Research (38 papers) and Glycosylation and Glycoproteins Research (20 papers). D M Goldenberg is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (38 papers), Monoclonal and Polyclonal Antibodies Research (38 papers) and Glycosylation and Glycoproteins Research (20 papers). D M Goldenberg collaborates with scholars based in United States, Germany and Belgium. D M Goldenberg's co-authors include F. James Primus, R M Sharkey, F. H. DeLand, Sidney Bennett, Robert M. Sharkey, H. J. Hansen, Rosalyn D. Blumenthal, M. Jules Mattes, Thomas M. Behr and Morton K. Schwartz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Journal of Clinical Oncology.

In The Last Decade

D M Goldenberg

83 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D M Goldenberg United States	29	1.4k	699	563	286	285	85	2.1k
A. A. Epenetos United Kingdom	24	1.5k 1.0×	527 0.8×	567 1.0×	405 1.4×	203 0.7×	68	2.1k
Agamemnon A. Epenetos United Kingdom	30	1.4k 1.0×	665 1.0×	1.1k 1.9×	407 1.4×	250 0.9×	84	2.5k
Paul G. Abrams United States	21	866 0.6×	519 0.7×	434 0.8×	452 1.6×	188 0.7×	50	1.8k
Paul L. Beaumier United States	25	1.4k 1.0×	480 0.7×	574 1.0×	218 0.8×	230 0.8×	37	1.9k
Guus A.M.S. van Dongen Netherlands	25	1.1k 0.8×	784 1.1×	617 1.1×	236 0.8×	416 1.5×	56	2.2k
G Bryant United States	17	533 0.4×	750 1.1×	394 0.7×	171 0.6×	161 0.6×	26	1.4k
Sidney Bennett United States	17	1.0k 0.7×	424 0.6×	424 0.8×	165 0.6×	196 0.7×	24	1.4k
Marijke Stigter‐van Walsum Netherlands	27	1.3k 0.9×	792 1.1×	948 1.7×	335 1.2×	399 1.4×	38	2.3k
Rhona Stein United States	35	1.8k 1.2×	1.3k 1.8×	866 1.5×	832 2.9×	383 1.3×	79	3.4k
J. Moore United Kingdom	14	917 0.6×	1.4k 2.0×	813 1.4×	383 1.3×	257 0.9×	25	2.4k

Countries citing papers authored by D M Goldenberg

Since Specialization

Citations

This map shows the geographic impact of D M Goldenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D M Goldenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D M Goldenberg more than expected).

Fields of papers citing papers by D M Goldenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D M Goldenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D M Goldenberg. The network helps show where D M Goldenberg may publish in the future.

Co-authorship network of co-authors of D M Goldenberg

This figure shows the co-authorship network connecting the top 25 collaborators of D M Goldenberg. A scholar is included among the top collaborators of D M Goldenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D M Goldenberg. D M Goldenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bardia, Aditya, Sara M. Tolaney, Delphine Loirat, et al.. (2020). LBA17 ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician’s choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC). Annals of Oncology. 31. S1149–S1150. 51 indexed citations

Kalinsky, Kevin, SJ Isakoff, SM Tolaney, et al.. (2019). Abstract P2-11-01: Safety and efficacy of sacituzumab govitecan (anti-Trop-2-SN-38 antibody-drug conjugate) as ≥3rd-line therapeutic option for treatment-refractory HER2-negative metastatic breast cancer (HER2Neg mBC). Cancer Research. 79(4_Supplement). P2–11. 3 indexed citations

Goldenberg, D M, et al.. (2016). Abstract P6-15-02: Synthetic lethality in TNBC mediated by an anti-Trop-2 antibody-drug conjugate, sacituzumab govitecan (IMMU-132), when combined with paclitaxel or the PARP inhibitor, olaparib. Cancer Research. 76(4_Supplement). P6–15. 1 indexed citations

Burton, J. D., et al.. (2010). Expression of CD74 by AML blasts and cell lines, and enhanced in vitro cytotoxicity of anti-CD74 antibody after interferon-gamma (IFN-γ) treatment.. Journal of Clinical Oncology. 28(15_suppl). 6576–6576. 2 indexed citations

Sharkey, R M, et al.. (2005). Improved therapy of non-Hodgkin's lymphoma xenografts using radionuclides pretargeted with a new anti-CD20 bispecific antibody. Leukemia. 19(6). 1064–1069. 39 indexed citations

Blumenthal, Rosalyn D., Elsa Leone, & D M Goldenberg. (2004). Tumor-specific dose scheduling of bimodal radioimmunotherapy and chemotherapy.. PubMed. 23(6C). 4613–9. 10 indexed citations

Modrak, David E., David V. Gold, D M Goldenberg, & Rosalyn D. Blumenthal. (2003). Colonic Tumor CEA, CSAp and MUC-1 Expression following Radioimmunotherapy or Chemotherapy. Tumor Biology. 24(1). 32–39. 24 indexed citations

Goldenberg, D M. (1997). Perspectives on oncologic imaging with radiolabeled antibodies. Cancer. 80(S12). 2431–2435. 6 indexed citations

Behr, Thomas M., D M Goldenberg, & W. Becker. (1997). Reduction of the renal accretion of radiolabeled antibody fragments and peptides. Nuclear Medicine Communications. 18(10). 974–974. 1 indexed citations

10.

Qu, Zhaoxia, et al.. (1997). Structure determination of N-linked oligosaccharides engineered at the CH1 domain of humanized LL2. Glycobiology. 7(6). 803–809. 5 indexed citations

11.

Moffat, F., Carl Pinsky, Luz Hammershaimb, et al.. (1996). Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab' antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum: results of a pivotal, phase III trial. The Immunomedics Study Group.. Journal of Clinical Oncology. 14(8). 2295–2305. 92 indexed citations

12.

Losman, Michele J., et al.. (1995). Engineering a unique glycosylation site for site-specific conjugation of haptens to antibody fragments.. The Journal of Immunology. 154(11). 5919–5926. 14 indexed citations

13.

Goldenberg, D M. (1994). New developments in monoclonal antibodies for cancer detection and therapy. CA A Cancer Journal for Clinicians. 44(1). 43–64. 29 indexed citations

14.

Sharkey, R M, et al.. (1990). Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans.. PubMed. 50(9). 2823–31. 49 indexed citations

15.

Blumenthal, Rosalyn D., R M Sharkey, Denise C. Snyder, & D M Goldenberg. (1989). Reduction by Anti-antibody Administration of the Radiotoxicity Associated With 131 I-Labeled Antibody to Carcinoembryonic Antigen in Cancer Radioimmunotherapy. JNCI Journal of the National Cancer Institute. 81(3). 194–199. 24 indexed citations

16.

Sharkey, Robert M., et al.. (1987). Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.. PubMed. 47(21). 5672–7. 54 indexed citations

17.

Goldenberg, D M, Alan Nevill, V. L. W. Go, et al.. (1981). CEA (carcinoembryonic antigen): Its role as a marker in the management of cancer. Journal of Cancer Research and Clinical Oncology. 101(3). 239–242. 105 indexed citations

18.

Nagell, John R. van, Elvis S. Donaldson, E. C. Gay, et al.. (1979). Carcinoembryonic antigen in carcinoma of the uterine cervix2. Tissue localization and correlation with plasma antigen concentration. Cancer. 44(3). 944–948. 28 indexed citations

19.

Goldenberg, D M, et al.. (1970). Reduced Lymphatic Drainage from Hamster Cheek Pouch. Experimental Biology and Medicine. 135(3). 724–726. 11 indexed citations

20.

Goldenberg, D M. (1970). Radiopotentiating Action of 1- -D-Arabinofuranosylcytosine in a. Experimental Biology and Medicine. 134(2). 510–512. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact